The tumor suppressor protein p53 is a transcription factor that is frequently mutated in human cancers. In response to DNA damage, p53 protein is stabilized and activated by post‐translational modifications that enable it to induce either apoptosis or cell cycle arrest. Using a novel yeast p53 dissociator assay, we identify hADA3, a part of histone acetyltransferase complexes, as an important cofactor for p53 activity. p53 and hADA3 physically interact in human cells. This interaction is enhanced dramatically after DNA damage due to phosphorylation event(s) in the p53 N‐terminus. Proper hADA3 function is essential for full transcriptional activity of p53 and p53‐mediated apoptosis.
The human tumor suppressor protein p53 induces cell cycle arrest or apoptosis in response to stress conditions, such as DNA damage, hypoxia or ribonucleotide depletion. It does so, in large part, as a homo‐tetrameric transcription factor that activates downstream effector genes, such as p21WAF1/CIP1/SDI1 for the mediation of G1 arrest (Ko and Prives, 1996; Levine, 1997; Giaccia and Kastan, 1998; Oren, 1999).
p53 has a very short half‐life in unstressed cells that is due primarily to a negative feedback mechanism with MDM2. MDM2 is a downstream target gene of p53; the protein binds to the p53 N‐terminus and induces ubiquitin‐mediated degradation of p53 (Haupt et al., 1997; Kubbutat et al., 1997). DNA damage activates kinases, such as ATM, ATR, DNA‐PK, hCHK1 and Chk2/hCds1, that phosphorylate serine residues in the N‐terminus of p53, thus stabilizing p53 by preventing MDM2 from binding to p53 (Giaccia and Kastan, 1998; Ashcroft and Vousden, 1999; Chehab et al., 2000; Hirao et al., 2000; Shieh et al., 2000). While the relative importance of these and other p53 modifications is still being worked out, it has become quite clear that a cascade of post‐translational modifications is required to stabilize p53 and fully activate it as a transcription factor (Giaccia and Kastan, 1998; Ashcroft and Vousden, 1999).
In this context, the effect of histone acetyltransferases (HATs) on p53 activity is particularly interesting. HATs are coactivators for many transcription factors. This activity initially was attributed entirely to their ability to relax chromatin at promoters by acetylating histones, but it quickly became clear that HATs regulate many other factors through acetylation, including transcription factors. The mechanisms that govern the timely and appropriate acetylation of transcription factors currently are largely unknown (Giles et al., 1998; Struhl, 1998; Kouzarides, 2000; Schiltz and Nakatani, 2000; Sterner and Berger, 2000).
Two homologous HATs, CBP (CREB‐binding protein) and p300, function as coactivators of p53 (Avantaggiati et al., 1997; Gu et al., 1997; Lill et al., 1997; Scolnick et al., 1997). p53 can be acetylated at specific lysine residues in the C‐terminus by p300/CBP and PCAF (p300/CBP‐associated factor), another HAT that frequently is associated with p300 or CBP (Yang et al., 1996; Gu and Roeder, 1997; Sakaguchi et al., 1998; Liu et al., 1999). This leads to a markedly increased affinity of p53 for p53 DNA‐binding sites in in vitro assays. N‐terminally phosphorylated p53 is a much better substrate for PCAF acetylation than non‐phosphorylated p53 (Sakaguchi et al., 1998). p53 acetylation occurs after many different types of cellular stress (Ito et al., 2001). Thus, p53 acetylation by HATs may be a universal and, probably, late post‐translational modification that fully activates p53 as a transcription factor.
HATs are part of multiprotein HAT complexes that were first identified in Saccharomyces cerevisiae. In yeast, these HAT complexes promote transcription by bridging transcriptional activators with the TATA‐binding protein (TBP). Besides several proteins that are responsible for the interaction with TBP, yeast HAT complexes contain yGcn5p, the HAT, and adaptor proteins, such as yAda2p and yAda3p, that interact with transcription factors (Grant et al., 1998; Sterner and Berger, 2000). PCAF and hGCN5 are both human homologs of yGcn5p, and hADA2 is homologous to yAda2p. The human homolog of yAda3p was identified by mass spectrometry after multiprotein HAT complexes were purified through interaction with FLAG‐tagged PCAF or hGCN5 (Ogryzko et al., 1998). While the activities of HATs are quite well characterized, the roles of many of the other components of human HAT complexes, including hADA3, remain to be established.
Using a novel yeast p53 dissociator assay, we isolated hADA3 in a p53 dissociator screen of a HeLa cDNA expression library. Our characterization of hADA3 establishes that hADA3 and p53 preferentially interact after DNA damage has occurred and that proper hADA3 function is required for full p53 activity.
The yeast p53 dissociator assay and p53 dissociator screens
The principles of the p53 dissociator assay have been described (Brachmann et al., 1996, 1998; Vidal et al., 1996). The reporter construct 1cUAS53::URA3 is activated by p53, thus enabling yeast cells to grow on medium lacking uracil (phenotype Ura+). Because the URA3 gene product is also involved in converting 5‐fluoro‐orotic acid (FOA) into a toxic substance, selection against p53 activity is possible as well (phenotype FOA‐sensitive, FoaS). The FoaS phenotype provides the essential tool to perform cDNA expression library screens (‘dissociator screens’). Proteins that interfere with p53 activity lead to a reduction of URA3 expression and, thus, growth on FOA plates (phenotype FOA‐resistant, FoaR). The p53 dissociator assay identifies proteins that inhibit p53, but proteins with very different functions in p53 biology are also isolated (see Figure 1).
The p53 dissociator assay was validated by transforming the haploid p53 reporter strain RBy41 with a plasmid expressing SV40 large T antigen (Clontech Laboratories), a viral antigen known to prevent DNA binding and transactivation by p53. SV40 large T antigen conferred an FoaR phenotype, while control strains were FoaS (Figure 1A). Our first p53 dissociator screen used a B‐cell cDNA expression library. A total of 5500 of 5.5 × 106 transformants in RBy41 were FoaR. Of these, 3350 clones were analyzed further, but yielded no dissociator plasmids. The high percentage of 0.1% false‐positives made screens in this form unfeasible. Further analysis established that 87% of false‐positive FoaR clones were due to recessive mutations in the URA3 reporter gene, 9% due to recessive p53 mutations and 4% due to dominant‐negative p53 mutations (Brachmann et al., 1996). This predicted that 96% of all false‐positives would be eliminated with a diploid reporter strain with two genomic copies each of the p53 expression cassette and the URA3 reporter gene. The resulting new diploid p53 reporter strain RBy99 performed as expected: in three library screens, a total of 9.95 × 106 transformants resulted in 384 false‐positives, representing 0.004% of all transformants (T.Kobayashi and R.K.Brachmann, unpublished data).
Figure 1B illustrates how p53 dissociator screens were performed. The cDNA expression library was transformed into RBy99, and transformants were placed on yeast plates selecting for the library plasmids. After 3–5 days, the lawn of transformants was replica plated (‘RP’) to selective plates containing FOA. FoaR clones emerged over the next 2–7 days. They were single colony purified and rechecked for the FoaR phenotype. After the plasmid dependency of the FoaR phenotype was determined, the plasmids were rescued and retransformed into RBy99 for phenotype confirmation prior to sequencing. A total of 1.5 × 105 transformants of a murine pre‐B‐cell cDNA expression library were screened and yielded 20 FoaR clones. Four clones passed all tests; their plasmids were identical and encoded murine Mdm2 (Figure 1C), a well characterized p53 inhibitor.
A p53 dissociator screen using a HeLa cell line‐derived cDNA expression library
We next screened a HeLa cDNA expression library. A total of 1.73 × 106 transformants yielded 294 FoaR clones. For 204, the FoaR phenotype was confirmed after single colony purification, and 113 of them showed plasmid dependency of the FoaR phenotype. Sixty‐one of the clones were FoaR upon retransformation of RBy99 after plasmid rescue. They represented seven candidate proteins not previously connected to p53, as well as 53BP1, a known p53 coactivator (Figure 1D; Iwabuchi et al., 1998).
hADA3 in the yeast p53 dissociator assay
One of the candidate proteins was hADA3 (eight of 61 library plasmids total, two independent clones; for phenotypes, see Figure 1D) that had just been identified as a component of multiprotein complexes containing either FLAG‐tagged PCAF or hGCN5 (Ogryzko et al., 1998). hADA3 may have scored as a dissociator in the yeast p53 assay for various reasons, such as creation of a non‐functional p53–hADA3 complex or disruption of endogenous yeast Ada complexes that are known to be required for p53 transcriptional acitivity in yeast (Candau et al., 1997). We decided to investigate the p53‐related role of hADA3 in human cells, because its function was unknown, and it had been physically linked to PCAF, one of the HATs that can acetylate p53. An expressed sequence tag (EST) clone for full‐length hADA3 (accession No. R17159; Ogryzko et al., 1998) was obtained, and expression plasmids for FLAG‐tagged full‐length hADA3 and the N‐ (amino acids 1–214) and C‐terminal (amino acids 215–432) halves were constructed (Figure 2A).
Full‐length hADA3 is 432 amino acids long, and both library clones lacked 5′ sequences [hADA3(aa119–432) and hADA3(aa168–432)]. hADA3 has 25% identity and 45% similarity with yAda3p; the C‐terminal half shows higher conservation, while the N‐terminal half of hADA3 is shorter and has significant gaps compared with yAda3p. Based on the alignment with and the biology of yAda3p, the N‐terminal half of hADA3 is predicted to interact with transcription factors, and the C‐terminal half with hADA2 and other components of HAT complexes (Figure 2A; Horiuchi et al., 1995; Candau and Berger, 1996; Ogryzko et al., 1998).
hADA3 interacts with components of HAT complexes
In yeast HAT complexes, the C‐terminal half of yAda3p physically interacts with yAda2p, which in turn interacts with the yeast HAT yGcn5p (Horiuchi et al., 1995; Candau and Berger, 1996). We used yeast two‐hybrid assays to establish the corresponding interaction between hADA3 and hADA2. Similarly to yeast, the C‐terminal half of hADA3 was required for this interaction (Figure 2B).
The complexes of FLAG‐tagged PCAF, hADA3 and other proteins surprisingly did not contain the HAT p300, even though PCAF had been described initially as a p300‐interacting protein (Yang et al., 1996; Ogryzko et al., 1998). Since both PCAF and p300 can acetylate p53, we investigated whether hADA3 can be found in complexes with p300 as well. hADA3 co‐immunoprecipitated p300, and the C‐terminal half of hADA3 was sufficient for the complex formation with p300 (Figure 2C). Analogously to the experiments with hADA2, the N‐terminal half of hADA3 was unable to co‐immunoprecipitate p300, suggesting that the C‐terminal half of hADA3 is crucial for linking it to HAT complexes.
hADA3 and p53 physically interact in human cells, and DNA damage dramatically enhances the interaction
We next determined whether hADA3 interacts with p53 in human cells. FLAG‐tagged hADA3 co‐immunoprecipitated endogenous wild‐type p53. The N‐terminal half of hADA3 was responsible for interaction with p53, while the C‐terminal half immunoprecipitated little or no p53 (Figure 3A). We then investigated whether post‐translational modifications of p53 modulate the interaction between hADA3 and p53 by subjecting the cells to γ‐irradiation‐induced DNA damage prior to co‐immunoprecipitation. Following γ‐irradiation, a dramatic increase in p53 co‐immunoprecipitated with FLAG‐tagged hADA3 was seen. In the same experiment, no change was found for p53 co‐immunoprecipitated with SV40 large T antigen. As previously described, γ‐irradiation resulted in increased levels of p53 protein phosphorylated at Ser15 (Figure 3B).
We further evaluated whether other types of DNA damage also lead to increased co‐immunoprecipitation of p53 and hADA3. Using H1299 cells with transfected p53 and U2OS cells with endogenous p53, an enhanced p53–hADA3 interaction similar to that produced by γ‐irradiation was seen in both cell lines after UV‐irradiation (Figure 3C).
We also demonstrated the interaction between endogenous hADA3 and endogenous p53 in U2OS and A549 cells (Figure 3D and E). Both cell lines have wild‐type p53 protein that is activated efficiently in U2OS cells by UV‐irradiation (Figure 6A) and in A549 cells by doxorubicin, a chemotherapy agent that causes DNA double strand breaks (Figure 7A). U2OS cells after UV‐irradiation showed an enhanced interaction between the endogenous proteins that was similar to experiments with FLAG‐tagged hADA3 (compare Figure 3C and D). However, the interaction between hADA3 and p53 was not enhanced in A549 cells after doxorubicin treatment (Figure 3E). This result may be specific for A549 cells and doxorubicin. Alternatively, it may indicate that the interaction between p53 and hADA3 is transient and highly regulated by other factors. In the case of overexpressed FLAG‐tagged hADA3, such cofactors may become limiting, thus leading to a more stable interaction between hADA3 and p53 that is then detected more readily in co‐immunoprecipitation experiments.
The enhanced interaction of hADA3 and p53 after DNA damage is governed by N‐terminal phosphorylation of p53
We next evaluated whether mutations 22Q23S in the p53 transactivation domain that result in a transcriptionally inactive p53 protein (Lin et al., 1994) also affect the interaction with hADA3. Without DNA damage, approximately equal amounts of wild‐type p53 and p53 22Q23S were immunoprecipitated with FLAG‐tagged hADA3, suggesting a basal interaction of p53 with hADA3 and possibly other factors. However, contrary to wild‐type p53, no increase of immunoprecipitated p53 22Q23S was seen after γ‐irradiation (Figure 4A), indicating that the p53 N‐terminus is important for the interaction with hADA3. The p53 N‐terminus contains seven serine residues that can be phosphorylated in response to stress signals, such as DNA damage (Giaccia and Kastan, 1998; Ashcroft and Vousden, 1999; Chehab et al., 2000; Hirao et al., 2000; Oda et al., 2000; Shieh et al., 2000). To determine whether one or more of these phosphorylation sites are important for the enhanced p53–hADA3 interaction, we tested a p53 mutant that has serines 6, 9, 15, 20, 33, 37 and 46 replaced by alanines. This p53 mutant (p53‐7A) did not show enhanced interaction with hADA3 after DNA damage, suggesting that phosphorylation events in the p53 N‐terminus govern the interaction with hADA3 (Figure 4B).
Full‐length hADA3 increases the transcriptional activity of p53
We then determined in reporter gene assays whether hADA3 influences p53 transcriptional activity in human cells (Brachmann et al., 1998). p53‐negative H1299 cells were transiently transfected with p53 and increasing amounts of FLAG‐hADA3. The results consistently showed a 2‐ to 4‐fold increase in p53 transcriptional activity (Figure 5A and B). The protein levels of p53 were unaffected by co‐expression of hADA3 (Figure 5A). The effect of hADA3 on reporter activation was p53 dependent, as hADA3 alone did not lead to luciferase expression. The stimulatory effect of hADA3 was only seen with overexpressed p53, suggesting that hADA3 is not limiting for endogenous p53 (data not shown).
The N‐terminal half of hADA3 inhibits p53 transcriptional activity
Our co‐immunoprecipitation and yeast two‐hybrid experiments (Figures 2 and 3) established that the C‐terminal half of hADA3 is responsible for the interaction with components of HAT complexes (hADA2 and p300) and that its N‐terminal half [hADA3(aa1–214)] interacts with p53. We reasoned that hADA3(aa1–214) might interfere with p53 transcriptional activity by creating a non‐functional complex with p53. Consistent with this, the N‐terminal half of hADA3 strongly inhibited p53 transcriptional activity in 293 cells with endogenous wild‐type p53. This dominant‐negative effect did not require the presence of an artificial nuclear localization signal (NLS; Figure 5C).
The N‐terminal half of hADA3 prevents p53‐mediated apoptosis
We investigated whether the reduction of p53 transcriptional activity in reporter gene assays by the N‐terminal half of hADA3 correlated with suppression of p53‐mediated apoptosis. U2OS cells with endogenous p53 were transfected with either vector control, SV40 large T antigen or hADA3(aa1–214) and membrane‐bound green fluorescent protein (GFP) (Kalejta et al., 1997), and were exposed to UV‐irradiation (20 J/m2). After 24 h, GFP‐positive cells were evaluated by fluorescence‐activated cell sorting (FACS) analysis for changes in the proportion of apoptotic cells, represented by the sub‐G1 fraction. hADA3(aa 1–214) dramatically and consistently reduced the fraction of apoptotic cells to <30% of the control, i.e. UV‐irradiation alone (Figure 6B; see Figure 6A for a representative FACS profile). This compared favorably with the effect seen with SV40 large T antigen. Very similar results were obtained in SW480 cells with mutant endogenous p53 in which apoptosis was triggered by overexpressing wild‐type p53. In the presence of hADA3(aa1–214) or SV40 large T antigen, the fraction of apoptotic cells was reduced to <20% of the control, i.e. transfected p53 alone (Figure 6D; see Figure 6C for a representative FACS profile).
hADA3 is required for full transcriptional activity of p53
We then explored whether removal of hADA3 using antisense oligomers would also result in a significant reduction of p53 activity. We chose A549 cells since exposure of these cells to doxorubicin leads to a >5‐fold increase in p53 transcriptional activity (Figure 7A) and since >90% of all cells take up antisense oligomers in a typical experiment (data not shown). Antisense oligomers 12555 and 12556 for hADA3 mRNA (Sequitur, MA) reduced p53 transcriptional activity to 35 and 43% of their specific negative controls, respectively (Figure 7B). The extent of p53 inhibition was similar to the reduction that was observed with antisense oligomers specific for luciferase and p53 mRNA (Sequitur, MA; Figure 7B). Both antisense oligomers specific for hADA3 mRNA reduced hADA3 protein to levels that corresponded well to the reduction in p53 activity, but did not affect p53 protein levels (Figure 7C).
A novel yeast p53 dissociator assay that is based on the principles of the reverse two‐hybrid system (Vidal et al., 1996) allowed us to identify hADA3 as an important player in p53 biology. The basic p53 dissociator assay was used previously to address other p53‐related questions, such as the characteristics of dominant‐negative p53 mutants and intragenic suppressor mutations for common p53 cancer mutations (Brachmann et al., 1996, 1998). We have optimized the p53 dissociator assay for highly efficient p53 dissociator screens to identify novel proteins important to p53 biology. This report establishes the feasibility of the reverse two‐hybrid technology for such dissociator screens. The same strategies can be applied to many other protein–protein or protein–DNA interactions of interest.
In our collection of candidate proteins obtained from a yeast p53 dissociator screen, hADA3 was particularly interesting since it is homologous to yAda3p, a yeast protein that functions as an adaptor between transcription factors and HAT complexes. The N‐terminus of yAda3p interacts with transcription factors, while its C‐terminus contributes to the formation of yeast HAT complexes by interacting with yAda2p (Horiuchi et al., 1995; Candau and Berger, 1996). Human HAT complexes have a very similar composition to yeast HAT complexes, and, like its yeast counterpart, hADA3 is part of HAT complexes (Ogryzko et al., 1998). HAT complexes enhance p53 transcriptional activity, probably through two mechanisms: full transcriptional activation of p53 as a result of C‐terminal acetylation by p300/CBP and PCAF (Gu and Roeder, 1997; Sakaguchi et al., 1998; Liu et al., 1999; Chao et al., 2000; Ito et al., 2001) and relaxation of chromatin at p53‐responsive promoters through acetylation of histones (Giles et al., 1998; Struhl, 1998; Schiltz and Nakatani, 2000; Sterner and Berger, 2000).
hADA3 was first isolated in multiprotein complexes with FLAG‐tagged PCAF or hGCN5, complexes that also contained hADA2 (Ogryzko et al., 1998). We show that, analogously to yAda3p, the C‐terminal half of hADA3 interacts with hADA2. Even though PCAF and p300 have been demonstrated to interact, p300 surprisingly was not identified in the purified multiprotein complexes (Yang et al., 1996; Ogryzko et al., 1998). In this report, we demonstrate that hADA3 complexes with p300 and that the C‐terminal half of hADA3 is responsible for this. Thus, hADA3 interacts with two HATs known to acetylate p53.
Using immunoprecipitation assays, we have clearly demonstrated an endogenous physical interaction between hADA3 and p53 in human cells. There appears to be a basal interaction between p53, hADA3 and probably other factors in the absence of DNA damage. This basal interaction between p53 and hADA3 is enhanced dramatically by γ‐ and UV‐irradiation. Thus, the interaction with hADA3 appears to be part of a general response of p53 to DNA damage.
We found that, in the absence of DNA damage, the transcriptionally inactive double mutant p53 22Q23S was immunoprecipitated with hADA3 in amounts similar to wild‐type p53. However, upon DNA damage, the basal interaction between the inactive p53 22Q23S and hADA3 was not augmented as was the interaction between wild‐type p53 and hADA3. These data establish that the p53 N‐terminus is instrumental in regulating the interaction with hADA3. The p53 mutant with alanines instead of serines at positions 6, 9, 15, 20, 33, 37 and 46 (p53‐7A) behaved similarly to p53 22Q23S in co‐immunoprecipitation experiments with hADA3. This further suggests that one or more specific phosphorylation event(s) in the p53 N‐terminus are required for the enhanced interaction with hADA3.
Recent data in two murine knock‐in models for the mutant p53 25Q26S, corresponding to the human mutant p53 22Q23S, showed that p53 25Q26S was transactivation deficient and unable to induce cell cycle arrest or apoptosis in response to DNA damage (Chao et al., 2000; Jimenez et al., 2000). While p53 25Q26S bound to p53 DNA‐binding sites constitutively, its DNA‐binding capacity did not increase with DNA damage, contrary to what was observed for wild‐type p53 (Jimenez et al., 2000). Strikingly, and in contrast to wild‐type p53, p53 25Q26S entirely lacked C‐terminal acetylation at Lys317 and Lys379 (corresponding to human Lys320 and Lys382) after DNA damage, despite phosphorylation at Ser18 (human Ser15; Chao et al., 2000). These and our results establish an intriguing correlation between transcriptionally inactive p53, absence of p53 acetylation and lack of an enhanced p53–hADA3 interaction after DNA damage.
In our experiments, full‐length hADA3 increased p53 transcriptional activity up to 4‐fold without concomitant increases in p53 protein levels in transient transfection experiments overexpressing both hADA3 and p53. yAda3p has no known enzymatic activity, making it unlikely that hADA3 had a stimulatory effect on p53 through direct post‐translational modifications of p53. A more likely scenario is that the endogenous level of hADA3 is not sufficient for the high level of overexpressed p53 protein. Thus, overexpression of hADA3 increases the pool of hADA3 protein, leading to enhanced p53 transcriptional activity.
The overexpression studies discussed above have established an important role for hADA3 in p53 transcriptional activity, and we have complemented these experiments with two loss‐of‐function analyses. In the first, we found that an N‐terminally truncated form of hADA3 [hADA3(aa1–214)] interacts with p53, but not components of HAT complexes, perhaps leading to a non‐functional complex with p53. We demonstrated that hADA3(aa1–214) had a strong dominant‐negative effect on p53 transcriptional activity and interfered with p53‐mediated apoptosis. In the second loss‐of‐function approach, we used two different antisense oligomers for hADA3 mRNA to substantiate further that p53 requires access to hADA3 for full transcriptional activity. The antisense oligomers reduced hADA3 protein levels and, as a consequence, p53 transcriptional activity. These data expand on previous experiments showing that yeast Ada3p, as well as yeast Ada2p and Gcn5p, are required for transcriptional activity of p53 in yeast (Candau et al., 1997).
p53 has been shown to interact directly with PCAF (Liu et al., 1999), p300 (Avantaggiati et al., 1997; Lill et al., 1997) and CBP (Gu et al., 1997; Scolnick et al., 1997), raising the question of how binding of p53 to hADA3 and various HATs is coordinated. Perhaps HATs are able to interact with p53 in vitro, but in living cells require the cooperation of additional factors to communicate efficiently with p53. In this case, hADA3 would promote a productive interaction between p53 and various HATs. This would be reminiscent of the differing abilities of HATs to acetylate free histones or nucleosomes depending on the absence or presence of a HAT complex (Struhl, 1998; Giles et al., 1998; Schiltz and Nakatani, 2000; Sterner and Berger, 2000). This scenario is also attractive as it provides a novel mechanism of specificity for HAT activities. By preferentially interacting with p53 protein that is stabilized through N‐terminal phosphorylation after DNA damage, hADA3 may ensure that p53 is only acetylated by HATs when appropriate. Strictly speaking, our data are also consistent with a role for hADA3 in p53 transcriptional activity that is independent of HATs. This appears less likely though, based on the physical linkage of hADA3 to PCAF and p300 and the correlative data for the mutant p53 22Q23S.
In summary, our data suggest that hADA3 is an important cofactor for the transcription factor p53. It is very likely that hADA3 plays this role in the context of HAT complexes. The enhanced interaction of hADA3 and p53 after DNA damage depends on N‐terminal phosphorylation event(s) of p53. The contribution of specific post‐translational modifications of p53 to the interaction with hADA3 needs to be explored further, since it may represent a novel mechanism of specificity that regulates interactions between p53 and HAT complexes based on the post‐translational state of p53. Likewise, it needs to be investigated whether and how absence of hADA3 function affects acetylation of p53. Since proper hADA3 function is required for full p53 activity, it raises the question of whether genetic alterations of hADA3 may account for decreased p53 activity in some human cancers with wild‐type p53.
Materials and methods
cDNA libraries, plasmids and plasmid constructions
The screened cDNA expression libraries were derived from the following: B‐cells (S.Malek and S.Desiderio, The Johns Hopkins University School of Medicine, Baltimore, MD, unpublished data), murine pre‐B‐cells (P.Stanhope and M.Schlissel, University of California, Berkeley, unpublished data) and the HeLa cell line [provided by M.Brasch, Life Technologies, Inc. (LTI)]. For the HeLa library, cDNAs were constructed using oligo(dT) NotI primers and 5′ SalI–MluI adaptors, as described in the Superscript Plasmid System, and ligated into SalI–NotI‐digested p2.5 (Vidal et al., 1996). The library had 2.1 × 107 primary clones of which 1 × 107 were amplified. The average insert size was 1.3 kb, and 91% of vectors had inserts.
The following plasmids were used: pTD1‐1 (Clontech Laboratories), pFLAG‐CMV2 (Sigma), pPCMVEGFPspectrin (Kalejta et al., 1997), p53 22Q23S in pRC/CMV (Lin et al., 1994), pJL134 with SV40 large T antigen (J.Li, unpublished data), CMVβ‐p300 (Eckner et al., 1994), pPC97 and pPC86 (Chevray and Nathans, 1992), pIC400 (Brachmann et al., 1998) and MG15‐Luc, PG13‐Luc, WWP‐Luc and pC53‐SN3 (Baker et al., 1990; el‐Deiry et al., 1993).
Mdm2 was isolated from the murine pre‐B‐cell, and hADA3(aa119– 432), hADA3(aa168–432) and 53BP1(aa971–1972) were isolated from the HeLa cDNA expression library. EST clones R17159 and AA856985 (Washington University Genome Sequencing Center, St Louis) were the cDNA sources for hADA3 and hADA2, respectively. The first 598 bp of hADA3 were PCR amplified with primers RB117 (GAAGCTTAT GAGTGAGTTGAAAGA) and RB118 (AGCGCTGGGAGTAGTGC TTC) to introduce a 5′ HindIII site. The PCR product was combined with the remainder of the hADA3 cDNA, and the entire cDNA was sequence verified. A similar strategy was used for hADA2; the first 313 bp were amplified with primers RB119 (GAAGCTTATGGCCCTTTTAGAAGC) and RB120 (ATTCTTGCAAATCGCCTCAT). For two‐hybrid assays, hADA3 and hADA2 were cloned into new versions of pPC97 and pPC86 (Chevray and Nathans, 1992) with markers TRP1 and LEU2, respectively. For experiments in mammalian cells, SV40 large T antigen, 53BP1(aa971–1972) and hADA3 were cloned into pFLAG‐CMV2 (Sigma). Truncated versions of hADA3 were constructed by digestion and religation of full‐length hADA3 expression plasmids. For the N‐terminal half of hADA3, this resulted in the addition of the peptide PLSK in the case of the two‐hybrid constructs and VASL for constructs in pFLAG‐CMV2. Constructs with an NLS were derived from full‐length hADA3 with an NLS in pFLAG‐CMV2. To obtain a matching set of expression plasmids for p53 and p53‐7A, the natural open reading frame (ORF) of p53 in pCMV‐p53 (Clontech Laboratories) was replaced with designer p53 ORFs (T.Wang and R.K.Brachmann, unpublished data) encoding wild‐type p53 or p53 with alanines at positions 6, 9, 15, 20, 33, 37 and 46.
Studies in S.cerevisiae
Techniques for yeast maintenance and the p53 dissociator assay have been described (Brachmann et al., 1996, 1998; Vidal et al., 1996). RBy99 resulted from the mating of two haploid strains, each containing the p53 expression cassette integrated at the LYS2 locus and the URA3 reporter construct. Two‐hybrid studies were performed in strain PJ69‐4A (James et al., 1996).
Cell culture, transfection and reporter gene assays
A549, H1299, 293 and SW480 cell lines were grown in high‐glucose Dulbecco's modified Eagle's medium (DMEM), and U2OS cells in McCoy 5A media, all with 10% fetal bovine serum. Lipofectamine (LTI) was used for all transfections, except for U2OS (SuperFect; Qiagen) and SW480 cells (Lipofectin; LTI). Reporter gene assays were performed as previously described (Brachmann et al., 1998). Immunoblotting was performed with the same, β‐galactosidase adjusted, lysates used for reporter gene assays. Anti‐p53 antibody PAb1801 (Oncogene Research Products, MA) was used at 2.5 μg/ml and anti‐FLAG M5 (Sigma) at 5 μg/ml.
Cells were seeded at 1 × 106 cells per 60 mm plate and transfected with 3 μg of total DNA. After 24 h, cells were either lysed, γ‐irradiated with 30, 50 or 80 Gy and lysed 1.5 h later, or UV‐irradiated with 50 J/m2 and lysed 3 h later. Cells were also exposed to doxorubicin (Sigma) at 0.4 μg/ml starting 1 h after transfection until lysis 24 h later. Cells were washed with phosphate‐buffered saline (PBS), treated with 1 mM dimethyl 3,3′‐dithiobispropionimidate (2HCl) (DTBP) for 20 min at room temperature (Xu and Reed, 1998) and lysed with 500 μl of ELB (50 mM HEPES, pH 7.2; 250 mM NaCl; 5 mM EDTA, pH 8.0; 0.5% NP‐40) containing protease and phosphatase inhibitors. After gentle rocking for 5 min, samples were pipetted up and down 6–8 times for 10 min, centrifuged twice at 20 800 g for 10 min and exposed to FLAG‐M2 beads (Sigma) for 1–2 h (0–4°C). Beads were washed three times with ELB and once with PBS, spun down for 2 min at 500 g, mixed with 20–30 μl of loading buffer and boiled for 4 min prior to standard immunoblotting analysis. The rabbit anti‐phospho‐p53 (Ser15) antibody (New England Biolabs, MA) was used at 1:1000, rabbit and goat anti‐p53 antibodies FL‐393(G) at 0.4 μg/ml and rabbit anti‐p300 antibody (C20) at 0.4 μg/ml (Santa Cruz Biotechnology).
To demonstrate the interaction of endogenous p53 and hADA3, five anti‐p53 antibodies, PAb421, PAb1620 (Oncogene Research Products, MA), PAb240, G59‐12 and PAb122 (BD Pharmingen) were cross‐linked to protein A– or protein G–agarose (Santa Cruz Biotechnology), with dimethyl pimelimidate (2HCl) (DMP) (Harlow and Lane, 1999), and a mixture of these was used to immunoprecipitate p53 from the lysate of five confluent 75 cm2 flasks of A549 or U2OS cells. Normal mouse IgG cross‐linked to protein A– and protein G–agarose was the negative control. Co‐immunoprecipitated hADA3 was detected using a rabbit polyclonal anti‐hADA3 antibody at 1:500 (Brand et al., 1999).
Apoptosis assays were performed as described (Ozoren et al., 2000). A total of 1 × 106 U2OS cells were transfected with either pFLAG‐CMV2, hADA3(aa1–214) or SV40 large T antigen and pPCMVEGFPspectrin, exposed to UV‐irradiation (20 J/m2) after 12 h, and 24 h later fixed in 70% ethanol overnight and stained with 50 μg/ml propidium iodide. SW480 cells additionally were transfected with pC53‐SN3 or pCMVneo and analyzed 24 h later. The results were normalized to the percentage of apoptotic cells above background (expressed as 100%) that were induced by UV‐irradiation (U2OS) or p53 transfection (SW480) alone.
Antisense oligomer experiments
All antisense reagents and protocols used for A549 cells were from Sequitur, MA. The sequences of the hADA3 oligomers are: 12555, UCAUGGUCUCGACCCAGCUUCAGGA; 12156 (negative control for 12555), UGCCCAGCUGGUCUCUCGAUCAAGA; 12556, AAUUAG CUCCUCCUUGAUGCGGCUC; 12070 (negative control for 12556), CAGUUGACGUCUCUGUAACUUCCCG.
We thank A.Beavis, A.Bedi, M.Brasch, S.Desiderio, E.Harlow, P.James, M.Kastan, S.Korsmeyer, A.Levine, J.Li, D.Livingston, S.Malek, D.Nathans, J.Nathans, M.Schlissel, P.Stanhope and B.Vogelstein for providing reagents. Special thanks go to Y.Nakatani who generously provided the polyclonal antibody against hADA3. We thank C.B.Brachmann and D.Dean for comments on the manuscript. R.K.B. thanks J.D.Boeke for his unwavering support of the idea of the p53 dissociator assay during its earlier phases in his laboratory. This work was supported in part by grants from the James S.McDonnell Foundation, the Concern Foundation, the Edward Mallinckrodt, Jr Foundation and National Institutes of Health grant CA87468 (R.K.B.).
- Copyright © 2001 European Molecular Biology Organization